0000000001205990

AUTHOR

Maria Inês Pereira

showing 1 related works from this author

G-CSF dosing schedule to prevent eribulin-induced neutropenia: Can modelling and simulation help?

2015

e20673 Background: Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer and should be administered on day 1 and 8 of each 21-day cycle. Neutrope...

OncologyCancer Researchmedicine.medical_specialtySchedulebusiness.industryNeutropeniamedicine.diseaseMetastatic breast cancerchemistry.chemical_compoundOncologychemistryInternal medicinemedicineMicrotubule InhibitorDosingIntensive care medicinebusinessEribulinJournal of Clinical Oncology
researchProduct